A poorly regulated grey market is growing online around unapproved peptides, which are being promoted on social media for ...

French Open finalist Alexander Zverev injected himself with insulin during Sunday's final against Flavio Cobolli to help ...

Use of automated insulin delivery during hospitalization may improve glycemic outcomes for adults with insulin-treated ...

A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with ...

A medical breakthrough is showing promise for Americans with Type 1 diabetes. It's an alternative for taking insulin without ...

For decades, human endocrinologists were trying to solve a parallel problem. Humans naturally produce a hormone called GLP-1 ...

So, how does Victoza compare to other GLP-1 medications, including semaglutide or tirzepatide? Here’s what you need to know ...

Glucagon-like peptide-1 receptor agonists, aka GLP-1s, are one of the best-known synthetic peptides and the active ingredient ...

Good afternoon, and welcome to the MannKind Corporation conference call to discuss the U.S. FDA approval of Afrezza in pediatrics. As a reminder, this call is being recorded on May 29, 2026, and will ...

Enables dosing at the start of a meal, offering flexibility for children and adolescents as they manage school, sports, meals, and snacks ...

Label expansion enables a rapid-acting inhaled mealtime insulin option for pediatric patients ≥6 years, addressing injection burden amid persistent unmet needs in youth diabetes management.

Over the past two years, I have fielded an increasing number of questions about peptides from readers, patients and ...